In a matched analysis, use of the dual GIP/GLP-1 receptor agonist was associated with reduced 12-month risks of diabetic ...

Sulfonylureas, short-acting, and medium-acting insulins for the treatment of diabetes mellitus type 2 may increase the risk of diabetic retinopathy, while fibrates and Cox-2 inhibitors may decrease it ...

This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...

In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...

Please provide your email address to receive an email when new articles are posted on . “Our study confirms that time in range, as well as time in tight target range, is associated with incident ...

Recent reports suggest diabetic retinopathy is more common in younger people than previously thought, leading to a call for more frequent screening for this condition and more attention to follow-up ...

Retinopathy refers to conditions or damage affecting the retina. Without treatment, it can cause blindness. Hypertensive retinopathy results from high blood pressure, while diabetic retinopathy is a ...

The prevalence of vision-threatening retinopathy in people with diabetes has increased exponentially in the past decade, most acutely among younger adults and Hispanic and Black populations, an ...

Diabetic retinopathy (DR) usually takes several years to develop. In many cases, it may take at least 5 years for the condition to develop after a diagnosis of diabetes. However, the onset, ...